Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5503446 | Maturitas | 2017 | 27 Pages |
Abstract
Metformin treatment is associated with a significant reduction in OM irrespective of diabetes status in patients with EC. The survival benefit suggests that diabetes screening and maintenance of good glycemic control may improve outcomes in EC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Faustino R. Perez-Lopez, Vinay Pasupuleti, Ximena Gianuzzi, Gabriela Palma-Ardiles, Wendy Hernandez-Fernandez, Adrian V. Hernandez,